Lifesci Acquisition Corp.
13F holders, Q3 2024 (September 30)2holders +1
1new positions
0sold out
$0.72avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Lifesci Acquisition Corp. in their 13F filings, up 1 from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were Hollencrest Capital Management ($7K) and Farther Finance Advisors, LLC ($7).
- Company
- Lifesci Acquisition Corp.
- Filed as
- VINCERX PHARMA INC COM NEW (Q3 2024)
- CUSIP
- 53228P109
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $7 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 10 shares bought, net +10 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Hollencrest Capital Management | 0.00% | No change | 10,000 | $7K |
| Farther Finance Advisors, LLC | 0.00% | New | 10 | $7 |
"% of holder's portfolio" is LIFESCI ACQUISITION CORP's weight in each manager's 13F, not the share of Lifesci Acquisition Corp. the manager owns.